Martingale Asset Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-56,919
| Closed | -$536K | – | 1106 |
|
|
2020
Q3 | $536K | Sell |
56,919
-2,100
| -4% | -$19.8K | 0.01% | 795 |
|
|
2020
Q2 | $452K | Buy |
59,019
+800
| +1% | +$6.13K | 0.01% | 895 |
|
|
2020
Q1 | $360K | Buy |
58,219
+1,100
| +2% | +$6.8K | ﹤0.01% | 861 |
|
|
2019
Q4 | $696K | Buy |
57,119
+6,500
| +13% | +$79.2K | 0.01% | 826 |
|
|
2019
Q3 | $585K | Hold |
50,619
| – | – | 0.01% | 855 |
|
|
2019
Q2 | $506K | Buy |
50,619
+4,300
| +9% | +$43K | 0.01% | 884 |
|
|
2019
Q1 | $597K | Buy |
46,319
+11,989
| +35% | +$155K | 0.01% | 860 |
|
|
2018
Q4 | $522K | Buy |
34,330
+18,895
| +122% | +$287K | 0.01% | 851 |
|
|
2018
Q3 | $309K | Buy |
+15,435
| New | +$309K | ﹤0.01% | 901 |
|
|
2017
Q1 | – | Sell |
-13,813
| Closed | -$481K | – | 1011 |
|
|
2016
Q4 | $481K | Buy |
+13,813
| New | +$481K | 0.01% | 832 |
|